Targeted therapeutic options in the treatment of Breast Cancer

Targeted therapeutic options in the treatment of Breast Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Бібліографічні деталі
Автор:	Alam, Kazi Tasnuva
Інші автори:	Kabir, Dr. Eva Rahman
Формат:	Дисертація
Мова:	en_US
Опубліковано:	Brac University 2022
Предмети:	Breast cancer Targeted therapy Biologics Biosimilars HER2 Trastuzumab Breast > Cancer > Patients Breast > Cancer > Treatment
Онлайн доступ:	http://hdl.handle.net/10361/17562

Схожі ресурси

A review on triple-negative breast cancer and its potential treatment
за авторством: Niasa, Jannatul Ferdous
Опубліковано: (2023)

Recent advancement on breast cancer detection and treatment
за авторством: Rahman, Sanjida
Опубліковано: (2023)

Natural products and their combinatory effects in breast cancer treatment
за авторством: Siddique, Md. Ayman
Опубліковано: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
за авторством: Chakraborty, Anuradha
Опубліковано: (2024)

Breast cancer awareness seminars
за авторством: Anwer Khan Modern Medical College
Опубліковано: (2016)

The impact of breast cancer on women’s lives in Bangladesh
за авторством: Mobashera, Tayeeba Tum
Опубліковано: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
за авторством: Akter, Honufa
Опубліковано: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
за авторством: Raihan, Dilraj
Опубліковано: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
за авторством: Parvin, Salma, та інші
Опубліковано: (2016)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
за авторством: Shobnam, Sohana
Опубліковано: (2024)

Breast cancer therapy through Liposomal drug delivery system
за авторством: Ome, Nusrat Jahan
Опубліковано: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
за авторством: Iqbal, Mohammad Shamim, та інші
Опубліковано: (2017)

Machine learning as an indicator for breast cancer prediction
за авторством: Shadman, Tahsin Mohammed, та інші
Опубліковано: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
за авторством: Araf, Faiaz Fahim
Опубліковано: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
за авторством: Lamia
Опубліковано: (2020)

Early detection of breast cancer using machine learning
за авторством: Fuad, Wasi Mohammad
Опубліковано: (2019)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
за авторством: Nuha, Nabiha Tahsin
Опубліковано: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
за авторством: Mirza, Maisa Tasnim
Опубліковано: (2023)

Breast cancer in South Asia: a Bangladeshi perspective
за авторством: Hossain, Mohammad Sorowar, та інші
Опубліковано: (2017)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
за авторством: Hasan, Sakib
Опубліковано: (2024)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
за авторством: Oishy, Jannatun Noor
Опубліковано: (2024)

Biosimilar in lymphoma treatment
за авторством: Tanisha, Mehrin Haque
Опубліковано: (2021)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

Breast cancer prediction using different machine learning models
за авторством: Khandker Al- Muhaimin, та інші
Опубліковано: (2020)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
за авторством: Kamal, Tasnova
Опубліковано: (2019)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
за авторством: Rahman, Qazi Ashrafur
Опубліковано: (2018)

Machine learning In breast cancer prognosis and prediction
за авторством: Chowdhury, Shah Abul Hasnat, та інші
Опубліковано: (2023)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
за авторством: Nahar, Kamrun
Опубліковано: (2023)

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

A comprehensive review on drug repurposing in cancer treatment
за авторством: Sarkar, Onusree
Опубліковано: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)

Stem cells as therapeutic carrier in cancer treatment
за авторством: Anika, Mysha Yeasmin
Опубліковано: (2022)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

Drug repurposing: search for targeted drug candidates in the treatment of HER2 positive breast cancer
за авторством: Yeasmin, Jahida
Опубліковано: (2024)

Microneedles in pain management of Cancer
за авторством: Islam, Shafiqul
Опубліковано: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
за авторством: Hasan, Amit
Опубліковано: (2024)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
за авторством: Alam, Tahera
Опубліковано: (2024)